These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 16050272

  • 21. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]

  • 22. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
    Calderone V, Testai L, Martinotti E, Del Tacca M, Breschi MC.
    J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
    [Abstract] [Full Text] [Related]

  • 23. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
    Milberg P, Frommeyer G, Uphaus T, Kaiser D, Osada N, Breithardt G, Eckardt L.
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):92-100. PubMed ID: 21964157
    [Abstract] [Full Text] [Related]

  • 24. QT prolongation is an unreliable predictor of ventricular arrhythmia.
    Hondeghem LM.
    Heart Rhythm; 2008 Aug; 5(8):1210-2. PubMed ID: 18675236
    [Abstract] [Full Text] [Related]

  • 25. QTc prolongation as a surrogate for drug-induced arrhythmias: fact or fallacy?
    Hondeghem LM.
    Acta Cardiol; 2011 Dec; 66(6):685-9. PubMed ID: 22299377
    [Abstract] [Full Text] [Related]

  • 26. Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia.
    Hondeghem LM, Dujardin K, De Clerck F.
    Cardiovasc Res; 2001 May; 50(2):345-53. PubMed ID: 11334838
    [Abstract] [Full Text] [Related]

  • 27. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D, Penland RC, stamps A, Traebert M, Dumotier B, Georgiva A, Helmlinger G, Lett GS.
    Prog Biophys Mol Biol; 2006 May; 90(1-3):414-43. PubMed ID: 16321428
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.
    Fabritz L, Kirchhof P, Franz MR, Eckardt L, Mönnig G, Milberg P, Breithardt G, Haverkamp W.
    Basic Res Cardiol; 2003 Feb; 98(1):25-32. PubMed ID: 12494266
    [Abstract] [Full Text] [Related]

  • 30. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA, Limberis JT, McDermott JS, Wegner CD, Cox BF.
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [Abstract] [Full Text] [Related]

  • 31. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
    Gallacher DJ, Van de Water A, van der Linde H, Hermans AN, Lu HR, Towart R, Volders PG.
    Cardiovasc Res; 2007 Nov 01; 76(2):247-56. PubMed ID: 17669388
    [Abstract] [Full Text] [Related]

  • 32. [Preclinical evaluation of drug induced QT prolongation].
    Hashimoto K.
    Nihon Yakurigaku Zasshi; 2003 Jun 01; 121(6):408-10. PubMed ID: 12899128
    [No Abstract] [Full Text] [Related]

  • 33. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.
    Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ.
    Cardiol J; 2008 Jun 01; 15(3):209-19. PubMed ID: 18651412
    [Abstract] [Full Text] [Related]

  • 34. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
    Lu HR, Gallacher DJ, Yan GX.
    J Pharmacol Toxicol Methods; 2016 Jun 01; 81():151-60. PubMed ID: 27374776
    [Abstract] [Full Text] [Related]

  • 35. Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
    Hondeghem LM.
    Drug Saf; 2018 Jan 01; 41(1):11-17. PubMed ID: 28853038
    [Abstract] [Full Text] [Related]

  • 36. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P, Reinsch N, Osada N, Wasmer K, Mönnig G, Stypmann J, Breithardt G, Haverkamp W, Eckardt L.
    Basic Res Cardiol; 2005 Jul 01; 100(4):365-71. PubMed ID: 15944809
    [Abstract] [Full Text] [Related]

  • 37. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA.
    Circulation; 2001 Nov 27; 104(22):2722-7. PubMed ID: 11723026
    [Abstract] [Full Text] [Related]

  • 38. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C, Sterneberg M, Kochhäuser S, Dechering DG, Fehr M, Eckardt L, Frommeyer G.
    Europace; 2018 Oct 01; 20(10):1699-1706. PubMed ID: 29377987
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms underlying arrhythmogenesis in long QT syndrome.
    Lankipalli RS, Zhu T, Guo D, Yan GX.
    J Electrocardiol; 2005 Oct 01; 38(4 Suppl):69-73. PubMed ID: 16226078
    [Abstract] [Full Text] [Related]

  • 40. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V.
    Neuropsychopharmacol Hung; 2004 Mar 01; 6(1):5-12. PubMed ID: 15125308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.